Where Will Dogecoin (DOGE) Be in 1 Year?
Summarize this article with:
By Alex Carchidi – Apr 20, 2026 at 6:00AM ESTKey PointsDogecoin doesn't have much in the pipeline for the next 12 months.The catalysts investors were banking on over the last 12 months didn't accomplish much.There is, however, one interesting possibility in play.Despite the wishes of many that it'd go to the moon, today Dogecoin (DOGE +0.06%) is close to 87% below its late-2021 peak, and it's down by 42% over the last 12 months. The king of all meme coins managed to pull a respectable run-up in late 2025, but the party is now definitively over. So what's coming next for Dogecoin over the next 12 months? Image source: Getty Images. Catalysts have fizzled For years, the bull case for Dogecoin -- as tenuous as that case was -- was focused on a short list of purported catalysts. There were hopes that Elon Musk would integrate it into his social media platform, X, formerly known as Twitter, thereby creating a new source of demand as well as a new place to spend DOGE. That didn't happen. Another narrative was that the approval of spot exchange-traded funds (ETFs) holding Dogecoin would create a new channel for institutional capital to flow into the coin. A few of those ETFs were actually approved in 2025, with another approved in 2026. None have assets under management (AUM) in excess of $16 million, so the total impact of the ETFs on the coin's price appears to be negligible as of now. ExpandCRYPTO: DOGEDogecoinToday's Change(0.06%) $0.00Current Price$0.09Key Data PointsMarket Cap$15BDay's Range$0.09 - $0.1052wk Range$0.08 - $0.30Volume1.7B Another idea was that regulators would grant it some legitimacy. In March 2026, a new jointly issued Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) framework for crypto classified Dogecoin as a digital commodity, meaning that it now shares the same classification as other, far more serious crypto investments. But gaining that regulatory clarity didn't do much of anything for the coin's price either. So, given the above, it's reasonable to assume that Dogecoin would need an even greater catalyst to meaningfully appreciate in price. There is one potential catalyst that's still in play. An independent project called DogeOS recently raised $6.9 million to build a smart contract layer that would dramatically increase Dogecoin's capabilities, but its mainnet isn't expected until the third quarter of 2026 at the earliest. And even that might not do much for the coin's price, as there are plenty of other far more capable and far more serious smart contract chains. Still, if Dogecoin gets a smart contract function, it'd be noteworthy, if perhaps not beneficial for the coin's price. This asset has nowhere to go Aside from its lack of features or mechanisms that'd give it value, Dogecoin has a structural problem that no amount of hype can ever paper over. Its network mints approximately 5 billion new DOGE every year, forever. The supply growth rate is roughly 3.4%, and while that percentage will shrink as the total supply grows, the dilution of holders never actually stops. Thus, for the coin's price to rise, demand must outpace its issuance every year, indefinitely -- and there aren't any drivers for demand. Therefore, a year from now, Dogecoin will likely trade in the same range it's in today, or perhaps lower. A more established crypto like Bitcoin or a stock with upside exposure to the crypto industry is a much safer bet for your investment dollars.Read NextApr 19, 2026 •By Dominic BasultoShiba Inu vs. Dogecoin: Which Meme Coin Is the Less Risky Bet?Apr 18, 2026 •By Alex CarchidiWill There Ever Be Another Dogecoin or Shiba Inu?Apr 17, 2026 •By Neil PatelThe Honest Truth About Investing in DogecoinApr 16, 2026 •By Anders BylundBest Crypto Stocks for 2026Apr 11, 2026 •By Chris NeigerWhere Will Dogecoin Be in 5 Years?Apr 2, 2026 •By Lyle DalyDogecoin vs. Shiba Inu: Is Either Worth Buying During the Crypto Crash?About the AuthorAlex Carchidi is a contributing Motley Fool healthcare and cryptocurrency analyst covering biotech, pharma, cannabis, and digital asset companies. Previously, Alex was a bench scientist and science writer at several biopharma companies and began his career as a researcher at the Ragon Institute of MGH, MIT, and Harvard. He holds a bachelor’s degree in biology from Boston University and a master’s degree in business administration with a concentration in finance from the University of Massachusetts Amherst.TMFacarchidiX@alexcarchidiStocks MentionedDogecoinCRYPTO: DOGE$0.09(+0.06%)+$0.00*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.